This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a possible sign of changes that occur in patients with frontal lobe ... (Read 16 times)

cnetterville

  • Hero Member
  • *****
  • Posts: 547
Which of the following is a possible sign of changes that occur in patients with frontal lobe malfunctions?
 
  a) delusions of grandeur and odd postures
   b) auditory hallucinations and depersonalization
   c) dissociative amnesia and migraine headaches
   d) diminished ability to concentrate and loss of orientation to time or place

Question 2

A physician suspects that a patient has a subtle form of brain damage that has not shown up on brain scans. The symptoms include apathy, overeating, reduced capacity to use language, and loss of orientation to time and place.
 
  A referral is made to a neuropsychologist. Which part of the brain might the neuropsychologist suspect has been damaged?
  a) parietal lobes
  b) corpus callosum
  c) cerebellum
  d) frontal lobes



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ktidd

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

d

Answer to Question 2

d





 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library